Company news
Cogent Biosciences, Inc. news in 2022
Cogent Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
December 10, 2022
Cogent Biosciences to Host Investor Webcast to Discuss Updated Clinical Data at ASH from the Ongoing Phase 2 APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis
December 4, 2022
Cogent Biosciences Appoints Rachael Easton, MD, Ph.D., VP, Head of Clinical Development
November 27, 2022
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
November 13, 2022
Cogent Biosciences Announces Bezuclastinib Presentations at the 64th Annual American Society of Hematology (ASH) Meeting
November 2, 2022
Cogent Biosciences to Showcase Precision Therapy Pipeline at the EORTC-NCI-AACR Annual Meeting
October 25, 2022
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2022 Financial Results
August 8, 2022
Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 15, 2022
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants
June 12, 2022
Cogent Biosciences Announces Positive Initial Clinical Data from Ongoing Phase 2 APEX Trial Evaluating Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
June 9, 2022
Cogent Biosciences to Host Investor Webcast on June 10, 2022 at 8: 00am ET
June 5, 2022
Cogent Biosciences Announces Annual Meeting of Stockholders
June 1, 2022
Cogent Biosciences Announces Presentation at European Hematology Association (EHA) Annual Congress
May 11, 2022
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2022 Financial Results
May 9, 2022
Cogent Biosciences to Participate in the LifeSci Partners Immunology and Inflammation Symposium
May 5, 2022
Cogent Biosciences Presents Nonclinical Data at AACR Annual Meeting and Provides Updates on Portfolio Expansion at R&D Investor Event
April 10, 2022
Cogent Biosciences to Host Virtual R&D Investor Event
March 28, 2022
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
March 14, 2022
Cogent Biosciences Announces Upcoming Presentations at AACR Annual Meeting 2022
March 7, 2022
Cogent Biosciences Provides 2022 Corporate Guidance
January 4, 2022
Decks in 2022
- American Society of Hematology Annual Meeting 2022
Conference · 22 slides · Dec 12, 2022
- European Hematology Association Congress 2022
Conference · 24 slides · Jun 10, 2022